Lataa...
Advances in anti-BRAF therapies for lung cancer
Non-small cell lung cancer (NSCLC) is one of the most frequent causes of mortality in the western world. v-raf murine sarcoma viral oncogene homolog B (BRAF) is a member of the Raf kinase family and plays a critical role in cellular growth, proliferation, and differentiation through the mitogen-acti...
Tallennettuna:
| Julkaisussa: | Invest New Drugs |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer US
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8068629/ https://ncbi.nlm.nih.gov/pubmed/33474634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-021-01068-8 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|